{
    "N/R/U": null,
    "Applicant": "Sarepta Therapeutics, Inc.",
    "BLA Number": "125781",
    "Proprietary Name": "ELEVIDYS",
    "Proper Name": "delandistrogene moxeparvovec-rokl",
    "BLA Type": "351(a)",
    "Strength": "1.33 \u00d710E14 vector genomes (vg)/kg/bodyweight(bw)",
    "Dosage Form": "Suspension",
    "Route of Administration": "Intravenous",
    "Product Presentation": "Single-Dose Vial",
    "Marketing Status": "Rx",
    "Licensure": "Licensed",
    "Approval Date": "June 22, 2023",
    "Ref. Product Proper Name": null,
    "Ref. Product Proprietary Name": null,
    "Supplement Number": "0",
    "Submission Type": "Original",
    "License Number": "2308",
    "Product Number": "001",
    "Center": "CBER",
    "Date of First Licensure": "June 22, 2023",
    "Exclusivity Expiration Date": null,
    "First Interchangeable Exclusivity Exp. Date": null,
    "Ref. Product Exclusivity Exp. Date": "June 22, 2035",
    "Orphan Exclusivity Exp. Date": "June 20, 2031",
    "drug": [
        {
            "name": "delandistrogene moxeparvovec-rokl",
            "drugbank_id": "https://go.drugbank.com/drugs/DB16802"
        }
    ]
}